Advertisement

Ibrutinib to Allogenic Stem Cell Transplant in a Case of Refractory Mantle Cell Lymphoma

  • Rayaz Ahmed
  • Jyotsna Kapoor
  • Narendra Agrawal
  • Priyanka Verma
  • Dinesh Bhurani
Correspondence

Notes

Acknowledgements

We thank all the members, staff of Rajiv Gandhi Cancer Institute and Research Centre, India for their contribution in the conduct of the study.

Compliance with Ethical Standards

Conflict of interest

All authors declare that they have no conflict of interest.

Ethical Approval

All procedures performed in study involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The study was approved by our Institutional Review Board.

Informed Consent

The informed consent was obtained from the individual participant included in the study.

References

  1. 1.
    Kroger N, Hoffknecht M, Kruger W, Zeller W, Renges H, Stute N et al (2000) Allogeneic bone marrow transplantation for refractory mantle cell lymphoma. Ann Hematol 79:578–580CrossRefPubMedGoogle Scholar
  2. 2.
    Wang ML, Blum KA, Martin P, Goy A, Auer R, Kahl BS et al (2015) Long-term follow-up of MCL patients treated with single-agent ibrutinib: updated safety and efficacy results. Blood 126(6):739–745CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Wang ML, Rule S, Martin P, Goy A, Auer R, Kahl BS et al (2013) Targeting BTK with ibrutinib in relapsed or refractory mantle-cell lymphoma. N Engl J Med 369(6):507–516CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Wang M, Goy A, Martin P, Ramchandren R, Alexeeva J, Popat R et al (2014) Efficacy and safety of single-agent ibrutinib in patients with mantle cell lymphoma who progressed after bortezomib therapy. Blood 124(21):4471Google Scholar
  5. 5.
    Chiron D, Di Liberto M, Martin P, Huang X, Sharman J, Blecua P et al (2014) Cell cycle reprogramming for PI3 K inhibition overrides relapse-specific C481S BTK mutation revealed by longitudinal functional genomics in mantle cell lymphoma. Cancer Discov 4(9):1022–1035CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Indian Society of Hematology and Blood Transfusion 2017

Authors and Affiliations

  • Rayaz Ahmed
    • 1
  • Jyotsna Kapoor
    • 1
  • Narendra Agrawal
    • 1
  • Priyanka Verma
    • 1
  • Dinesh Bhurani
    • 1
  1. 1.Department of Hemato-OncologyRajiv Gandhi Cancer Institute & Research CentreNew DelhiIndia

Personalised recommendations